Connect with us

Hi, what are you looking for?

Friday, Sep 22, 2023
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


Beckley Waves establishes ethics council for the psychedelics sector

Beckley Waves was created by the Beckley Foundation’s Founder Amanda Feilding

Beckley Waves establishes Ethics Council for the psychedelics sector
The Beckley Foundation's Founder Amanda Feilding (centre) with Pam Kryskow (left) and Paul Stamets (right), three members of the new council. Photo via the Beckley Foundation

The Beckley Foundation’s new venture studio for investments in the psychedelics sector has established an ethics council to help guide the industry.

Beckley Waves — the foundation’s investment arm — announced the formation of the council on Thursday, which is intended to set the standard for ethical and sustainable practices in the ever-growing psychedelics landscape.

The council was established during an inaugural summit meeting for world psychedelics leaders hosted by Beckley Waves and led by Amanda Feilding, Founder of the foundation.

Key members of the council will include Feilding; Rick Doblin, Founder of the Multidisciplinary Association for Psychedelic Studies (MAPS); the renowned mushroom expert Paul Stamets; and Dr. Pamela Krsykow, a physician and Co-Founder of MycoMedica Life Sciences, a psychedelics company that raised $60 million last year for the development of its fungi-based drugs.

The council will be inviting others to join as its agenda and scope of work develops and grows over time.

Read more: European Parliament launches medical psychedelics action group

Read more: New survey aims to gather data on psychedelics use worldwide

The renowned publication The Economist called Feilding the “Queen of Psychedelics” last year for her contributions to the field, such as hosting a series of international seminars about psychedelics and cannabis at the United Kingdom’s House of Lords in the late 1990s and co-authoring over 80 articles published in peer-reviewed journals.

The Beckley Foundation was founded by Feilding 25 years ago and has been a significant influence in the field of psychedelics research.

“With this council of advisors and experts, we have access to a great resource that will enable Beckley Waves to expand upon our established foundation and strengthen our capabilities and offerings across this nascent sector,” said Feilding.

Beckley Waves says that as the demands and expectations for the industry grow a higher level of responsibility in maintaining the sector inherently comes with them.

“While the psychedelics industry is in its infancy, these compounds and practices have been used for millennia by Indigenous peoples,” said Neil Markey, CEO and Co-Founder at Beckley Retreats, another branch of the foundation that runs psychedelic retreat centres in the Netherlands and Jamaica.

“As we look to set the standards for industry best practices, we must look to modern science and ancient wisdom.”

Feilding recently co-founded Beckley Psytech, a private company focused on developing a catalogue of psychedelic medicines for the treatment of mental and physical health conditions.

Doblin’s organization MAPS is currently in the midst of conducting an online survey to gather data on psychedelics that will be running until June 2.

The European Parliament also founded an “Action Group” for the medical use of psychedelics last week, which is intended to help establish safe and ethical practices while benefiting the sector as well.


Follow Mugglehead on Twitter

Follow Rowan Dunne on Twitter

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


It now has 19 million shares of the psychedelic drug developer, the firm's first investment in a public entity of this variety


The study findings represent the culmination of more than two decades of dedicated research efforts


Funds will be used to study psilocybin and MDMA-assisted therapy; non-profit says Sweden needs to 'catch up' in this area of research


Silo's SPC-15 was developed in collaboration with Columbia University